Power failure in acute myocardial infarction.
D000790:Angiocardiography; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000628:therapy; D001243:Assisted Circulation; D001794:Blood Pressure; D002302:Cardiac Output; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006333:Heart Failure / Q000503:physiopathology*; D006339:Heart Rate; D006439:Hemodynamics; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008168:Lung / Q000503:physiopathology; D009203:Myocardial Infarction / Q000503:physiopathology* / Q000601:surgery; D009638:Norepinephrine / Q000627:therapeutic use; D011379:Prognosis; D011652:Pulmonary Circulation; D012039:Regional Blood Flow; D014655:Vascular Resistance
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D005934:Glucagon; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine